Effects of erdosteine on cyclosporine-Ainduced hepatotoxicity in rats

Drug and Chemical Toxicology

Volumn 34, Issue 1, 2011, Pages 32-37

  Erarslan, Elife ^a   Ekiz, Fuat ^b   Uz, Burak ^a   Koca, Cemile ^a   Turkcu, Ummuhani Ozel ^c   Bayrak, Reyhan ^a   Delibasi, Tuncay ^b  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b Diskapi Yildirim Beyazit Educational and Research Hospital   (Turkey)

^c MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

Author keywords

Antioxidant action; Cyclosporine A; Erdosteine; Hepatotoxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CYCLOSPORIN A; ERDOSTEINE; FREE RADICAL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MALE; MICROSCOPY; NONHUMAN; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; CATALASE; CYCLOSPORINE; DRUG-INDUCED LIVER INJURY; GLUTATHIONE PEROXIDASE; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER FUNCTION TESTS; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOGLYCOLATES; THIOPHENES;

HELIANTHUS; RATTUS;

EID: 78649966343     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2010.483519     Document Type: Article

References (35)

1. Abuja, P. M., Albertini, R. (2001). Methods for monitoring oxidative stresss, lipid peroxidation, and oxidation resistance of lipoproteins. Clin Chim Acta 306:1-17.
2. Actis, G. C., Debernardi-Venon, W., Lagget, M., Marzano, A., Ottobrelli, A., Ponzetto, A., et al. (1995). Hepatotoxicity of intravenous cyclosporine A in patients with acute ulcerative colitis on total parenteral nutrition. Liver 15:320-323.
3. Aebi, H. (1974). Catalase. In: Bergmeyer, H. U. (Ed.), Methods of enzymatic analysis (pp 673-677). New York: Academic Press.
4. Andrés, D., Díez-Fernández, C., Zaragoza, A., Alvarez, A., Cascales, M. (2000). Changes in antioxidant defense systems induced by cyclosporine A in cultures of hepatocytes from 2-and 12-month-old rats. Biochem Pharmacol 59:1091-1100.
5. Bianchi, R., Rodella, L., Rezzani, R. (2003). Cyclosporine A upregulates expression of matrix metalloproteinase 2 and vascular endotelial growth factor in rat heart. Int Immunopharmacol 3:427-433.
6. Braga, P. C., Dal Sasso, M., Zuccotti, T. (2000). Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts. Arzneim Forsch 50:39-46.
7. Cortas, N. K., Wakid, N. W. (1990). Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440-1443.
8. Dechant, K. L., Noble, S. (1996). Erdosteine. Drugs 52:875-881.
9. Durak, I., Kaçmaz, M., Cimen, M. Y., Büyükkoçak, S., Elgün, S., Oztürk, H. S. (2002). The effect of cyclosporine on antioxidant enzyme activities and malondialdehyde levels in rabbit hepatic tissues. Transpl Immunol 10:255-258.
10. Durak, I., Ozbek, H., Elgun, S. (2004). Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants. Int Immunopharmacol 4:469-473.
11. Duruibe, V. A., Okonmah, A., Blyden, G. T. (1989). Effect of cyclosporine on rat liver and kidney glutathione content. Pharmacology 39:205-212.
12. Esterbauer, H., Cheeseman, K. H. (1990). Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. In: Packer, L., Glazer, A. N. (Eds.), Oxygen radicals in biological systems methods in enzymology (pp 407-421). San Diego, California, USA: Academic Press.
13. Fadillioglu, E., Erdogan, H. (2003). Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats. Pharmacol Res 47:317-322.
14. Galan, A. I., Munoz, M. E., Jimenez, R. (1999). S-adenosylmethionine protects against cyclosporine A-induced alterations in the rat liver plasma membrane fluidity and functions. J Pharmacol Exp Ther 290:774-781.
15. Grieve, D. J., Shah, A. M. (2003). Oxidative stresss in heart failure. More than just damage. Eur Heart J 24:2161-2163.
16. Gutteridge, J. M. C. (1995). Lipid peroxidation and antioxidant as biomarkers of tissue damage. Clin Chem 14:1819-1828.
17. Hagar, H. H. (2004). The protective effect of taurine against cyclosporine A-induced oxidative stresss and hepatotoxicity in rats. Toxicol Lett 15:1335-1343.
18. Inselmann, G., Lawerenz, H. U., Nellessen, U., Heidemann, H. T. (1994). Enhancement of cyclosporine A-induced hepto-and nephrotoxicity by glutathione depletion. Eur J Clin Invest 24:355-359.
19. Jaeschke, H. (2000). Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 15:718-724.
20. Kuvandik, G., Duru, M., Nacar, A., Yonden, Z., Helvaci, R., Koc, A., et al. (2008). Effects of erdosteine on acetaminophen-induced hepatotoxicity in rats. Toxicol Pathol 36:714-719.
21. Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A. G., et al. (1990). Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 186:464-478.
22. Lowry, O. H., Rosebrough, N. J., Farr, A. L. (1951). Protein measuremnet with the Folin-phenol reagent. J Biol Chem 193:265-275.
23. Meister, A. (1983). Selective modification of glutathione metabolism. Science 22:472-478.
24. Moretti, M., Marchioni, C. F. (2007). An overview of erdosteine antioxidant activity in experimental research. Pharmacol Res 55:249-254.
25. Paglia, D. E., Valentina, W. N. (1967). Studies on quantitative and qualitative characterization of erythrocte glutathione peroxidase. J Lab Clin Med 70:158-169.
26. Rezzani, R. (2004). Cyclosporine A and adverse effects on organs: histochemical studies. Prog Histochem Cytochem 39:85-128.
27. Sahin, S., Sogut, S., Ozyurt, H., Hüseyin, Ö., Efkan, U., Atilla., I., Ömer, A. (2002). Tissue xanthine oxidase activity and nitric oxide levels after spinal cord ischemia/reperfusion injury in rabbits: comparison of caffeic acid phenethyl ester (CAPE) and methylprednisolone. Neurosci Res Commun 31:111-121.
28. Sener, G., Sehirli, A. O., Toklu, H. Z., Yuksel, M., Ercan, F., Gedik, N. (2007). Erdosteine treatment attenuates oxidative stresss and fibrosis in experimental biliary obstruction. Pediatr Surg Int 23:233-241. (Pubitemid 46295035)
29. Sun, Y., Oberley, L. W., Li, Y. (1988). A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497-500.
30. Terzi, A., Iraz, M., Sahin, S., Ilhan, A., Idiz, N., Fadillioglu, E. (2004). Protective effects of erdosteine on rotenone-induced oxidant injury in liver tissue. Toxicol Industr Health 20:141-147.
31. Wang, C., Salahudeen, A. K. (1995). Lipid peroxidation accompanies cyclosporine nephrotoxicity: effect of vitamin E. Kidney Int 47:927-934.
32. Yagmurca, M., Bas, O., Mollaoglu, H., Sahin, O., Nacar, A., Karaman, O., et al. (2007). Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats. Arch Med Res 38:380-385.
33. Yagmurca, M., Fadillioglu, E., Erdogan, H., Ucar, M., Sogut, S., Irmak, M. K. (2003). Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacol Res 48:377-382.
34. Yesildag, A., Ozden, A., Yilmaz, H. R., Uz, E., Agackiran, Y., Yesildag, M., et al. (2009). Erdosteine modulates radiocontrastinduced hepatotoxicity in rat. Cell Biochem Funct 27:142-147.
35. Zachariane, H. (1999). Renal toxicity of long-term cyclosporine. Scand J Rheumatol 28:65-68.